Vilafranca Del Penedes

The registry focuses on patients with venous thromboembolism VTE, including those often excluded from typical clinical trials such as pregnant women, elderly patients, and those with serious health conditions. It aims to improve medical knowledge and patient care by collecting detailed data on these patients clinical status and treatment outcomes. The project also seeks to develop predictive scores to identify patients at higher risk of complications from thromboembolic disease. This observational registry collects extensive information on patients diagnosed with VTE, including details on coexisting conditions, antithrombotic treatment type, dose, and duration, as well as outcomes during the first three months of therapy. It captures data on VTE recurrences, bleeding complications, and deaths, providing insights into real-world treatment and patient management. Participants provide informed consent and are followed for at least three months to monitor clinical outcomes. The registry supports physicians by giving access to data on patients with similar profiles to help manage complex cases. The main outcomes measured include VTE events and complications over a three-year period, supporting ongoing improvements in patient care and risk assessment.

Researchers are evaluating two different care models for patients with type 2 diabetes who have poor blood sugar control. The study compares the effects of care provided in a day hospital setting by a nurse and endocrinologist to care centered on follow-up by a dietitian-nutritionist and an endocrinologist in an ambulatory care unit. The main goal is to assess how these models affect glycated hemoglobin HbA1c levels after three months. Participants receive either joint care from a nurse and endocrinologist in a day hospital before 2024 or care from a dietitian-nutritionist followed by an endocrinologist in outpatient care after 2024. These two approaches aim to manage diabetes differently, and the study observes their impact on metabolic control. During the study, researchers measure the participants glycated hemoglobin levels three months after completing the intervention to evaluate metabolic control. Participants continue regular clinical follow-up according to their assigned care model, and no additional treatments or procedures are specified. The study is observational and involves adults aged 18 and older with type 2 diabetes on insulin therapy.

Researchers are evaluating the safety of remote consultations, including video and telephone calls, compared to traditional face-to-face visits for patients followed up in a hospital setting. This randomized-controlled trial involves 2136 patients and aims to determine if remote consultations lead to a similar rate of complications related to the underlying diseases. The study excludes patients who require physical exams or have impairments affecting communication, as well as those involved in other clinical trials with experimental treatments. Participants will be randomly assigned to one of three groups face-to-face consultations, telephone consultations, or video consultations. In the face-to-face group, patients will have in-person appointments with limited phone interactions allowed. For the remote consultation groups, patients will receive reminders and either wait for a phone call or join a virtual waiting room for video calls. Physicians schedule visits as needed, including baseline, intermediate, and final visits within approximately one year. During the study, participants will undergo at least three visits, including initial screening, follow-ups, and a final visit around 12 months after enrollment. Researchers will monitor the frequency of disease complications, treatment adverse reactions, hospitalizations, unscheduled medical contacts, and healthcare costs. They will also assess the usability of the video system and satisfaction of both patients and health professionals. The study observes patients outcomes and safety throughout this period.